Then combining evidences from clinical data, in vitro and in vivo experiments, we revealed that lower NDFIP1 led to lower TAZ packaged in exosomes and higher TAZ accumulation in cells, promoting cell proliferation and tumor growth eventually. Here, NDFIP1 is linked to neoplasm.